Standard Biotools LAB Cash Flow Statement (2010-2026)

NASDAQ LAB
$0.65 +0.01 (+2.34%)
As of: Oct 21, 2026 · 11:41 AM EDT
Reported Financials

Standard Biotools Quarterly Cash Flow Statement

Periods 65 quarters
Latest Jun 2026

Standard Biotools reported cash from operations of -$10.31M and free cash flow of -$10.65M for the quarter ended Jun 2026, up 50.1% year over year. This cash flow statement covers 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-13.84M-9.43M-76.29M-63.54M-29.43M-20.85M-16.84M-17.04M-21.00M-19.78M-32.16M-45.72M-26.94M-34.07M-26.03M-33.46M-34.69M19.28M127.07M-26.76M
Depreciation and DepletionDep. & Depletion
0.70M3.00M1.00M1.00M0.80M2.10M2.00M1.50M1.30M1.40M1.30M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
2.98M2.97M2.97M2.80M2.80M2.80M2.80M2.11M0.72M0.71M0.81M0.90M0.82M
Amortization of Deferred ChargesAmort. Deferred Charges
0.22M0.20M0.21M0.21M0.21M0.20M0.20M0.21M0.19M0.17M
Depreciation & Amortization (CF)Dep. & Amort.
2.98M-5.29M1.00M0.88M0.80M0.82M0.86M0.83M1.19M1.11M3.09M3.14M3.15M3.14M3.27M3.18M1.52M1.29M1.41M1.27M
Share-based CompensationStock Comp.
4.32M4.36M4.04M4.66M4.49M1.68M3.15M3.11M3.39M3.48M11.61M3.41M4.65M7.47M9.01M5.37M7.54M5.74M8.82M4.05M
Cash from Discontinued OperationsCash from Discont. Ops
2.66M15.79M-141.69M5.23M
Gains from Sales and DivestituresGains Divest
-0.01M-0.01M172.29M
Gains from Investment SecuritiesGains Investment
-10.66M-3.06M-3.49M0.95M
Asset Writedowns and ImpairmentWritedown
Other non-cash itemsOther Non-Cash
0.29M0.75M0.85M3.75M2.64M4.22M1.30M0.20M0.40M1.48M-22.21M1.79M5.42M2.85M2.05M2.32M
Change in Working Capital
Change in ReceivablesChange Receivables
-2.02M4.71M-2.92M-4.36M6.15M0.06M-3.03M0.79M1.56M3.67M-0.69M-4.33M2.74M-6.70M2.02M0.28M5.79M-6.73M1.86M-1.25M
Change in InventoryChange Inventory
-0.02M-2.69M3.56M2.93M1.33M0.66M1.09M0.85M1.32M1.66M6.33M6.45M2.13M-5.03M3.82M4.73M1.80M1.17M-1.94M-1.25M
Change in Account PayablesChange Payables
-0.49M-0.13M1.91M-3.62M0.21M-1.28M-1.84M0.06M1.29M2.10M-10.28M-0.41M-2.19M-0.09M-0.58M1.42M0.95M0.65M-1.22M1.67M
Change in Accured ExpensesChange Accured Exp.
-0.75M1.41M4.79M0.74M2.50M1.36M-0.41M-2.64M-7.75M9.24M8.77M0.10M-20.79M6.65M
Change in Other Operating AssetsOther Assets Change
0.13M-2.28M0.04M1.27M-1.22M-0.12M-0.96M0.53M-0.32M-0.11M1.41M1.88M-0.57M-0.79M-0.11M1.67M0.32M-3.02M1.59M1.04M
Change in Other Operating LiabilitiesOther Liabilities Change
-5.84M-7.02M1.85M-4.41M-0.07M-9.93M0.06M0.20M-2.80M-0.29M-7.66M-0.98M-3.79M-1.77M-1.93M-2.89M-0.95M-2.17M-31.42M-1.81M
Other Working Capital ChangesOther WC Changes
-5.97M-4.74M1.81M-5.67M1.15M-9.81M1.01M-0.33M-2.47M-0.18M-9.07M-2.86M-3.21M-0.98M-1.82M-4.57M-1.27M0.85M-33.02M-2.85M
Other Operating ActivitiesOther Ops.
0.07M0.12M0.10M0.07M-0.01M1.16M0.06M0.27M0.28M0.33M0.29M0.58M0.24M-0.09M0.39M0.09M0.45M-0.02M0.07M-0.02M
Cash from OperationsCash from Ops.
-9.49M-7.00M-15.59M-29.99M-24.61M-19.18M-8.49M-9.33M-11.41M-14.06M-62.48M-39.05M-27.87M-14.06M-30.28M-20.67M-22.20M-1.19M-46.60M-10.31M
Investing Activities
Capital ExpendituresCapex
1.71M0.46M0.87M0.94M1.26M0.76M1.01M0.84M0.91M0.08M0.78M1.94M2.26M3.38M5.05M1.89M0.89M0.48M0.57M0.34M
Change in Property, Plant and EquipmentChange in PP&E
-1.71M-0.46M-0.87M-0.94M-1.26M-0.76M-1.01M-0.84M-0.91M-0.08M-0.78M-1.94M-2.26M-3.38M-5.05M-1.89M-0.89M-0.48M-0.57M-0.34M
Change in IntangiblesChange Intangibless
Acquisitions
280.03M1.39M
Divestments
363.22M24.99M
Net of Acquisitions & DivestmentsNet Acquisitions
-280.03M-1.39M363.22M24.99M
Purchase of InvestmentsInvestments Purchased
137.30M6.84M49.02M-55.86M73.18M74.81M78.63M-226.61M50.93M59.80M-103.87M0.84M237.06M
Sale and Maturity of InvestmentsInvestments Sold
12.00M41.00M51.00M40.96M26.00M112.00M127.00M50.00M60.00M52.00M48.00M54.00M25.00M15.00M41.09M
Other Investing ActivitiesOther investing
Cash from Investing ActivitiesCash from Investing
-1.71M-1.15M-0.87M-138.24M10.74M40.25M43.15M40.13M-49.93M-13.12M318.08M50.26M-30.88M25.73M14.63M27.51M-6.68M-8.04M191.09M14.41M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
10.00M6.84M25.00M
Long-Term Debt RepaymentsLT Debt Repayment
6.84M0.83M1.25M8.19M55.00M
Non-Current Debt
10.00M6.84M18.16M-0.83M-1.25M-8.19M-55.00M
Short-Term Debt repaymentsST Debt Repayment
6.84M
Current Debt
-6.84M
Net Debt Issuances and RepaymentsNet Debt Issuance
10.00M6.84M11.32M-0.83M-1.25M-8.19M-55.00M
Change in Capital Stock
Common Stock IssuedStock Issued
0.00M0.60M0.10M0.32M0.08M0.42M0.07M1.41M0.07M0.53M0.31M0.75M0.08M0.12M
Shares Repurchased
0.56M2.47M2.40M0.40M0.17M11.05M29.44M
Net Shares Issued and RepurchasedNet Shares Issued
0.00M0.60M0.10M-0.24M-2.47M-2.40M-0.32M0.25M-10.98M-28.03M0.07M0.53M0.31M0.75M0.08M0.12M
Net Equity Issued and RepurchasedNet Equity Issued
0.00M0.60M0.10M-0.24M-2.47M-2.40M-0.32M0.25M-10.98M-28.03M0.07M0.53M0.31M0.75M0.08M0.12M
Other financing activitiesOther financing
-0.18M-0.14M-0.09M-12.54M-0.10M-0.03M-0.09M-0.04M-0.01M-0.56M-0.33M-0.07M-0.05M-0.05M-0.20M-0.11M-0.13M-0.12M-0.26M
Cash from Financing ActivitiesCash from Financing
9.82M7.30M18.08M212.96M-0.01M-0.27M-2.56M-2.08M-1.16M-1.00M-19.73M-28.36M0.00M-54.52M-0.05M0.11M-0.11M0.62M-0.04M-0.14M
Additional items
Exchange Rate EffectFX Effect
-0.18M-0.01M-0.09M-0.35M-0.28M0.32M0.02M-0.07M-0.15M0.23M-0.02M-0.09M-0.41M-0.27M0.36M0.79M-0.20M-0.10M0.12M0.29M
Change in Cash
-1.55M-0.86M1.53M44.38M-14.16M21.11M32.13M28.64M-62.65M-27.95M235.85M-17.24M-59.16M-43.12M-15.35M7.73M-29.20M-8.71M144.57M4.25M
Ending Cash Balance
30.33M29.47M31.00M75.38M61.22M82.32M114.46M143.10M52.50M
Free Cash FlowFCF
-11.20M-7.47M-16.46M-30.93M-25.88M-19.94M-9.50M-10.17M-12.32M-14.14M-63.26M-40.99M-30.12M-17.44M-35.34M-22.56M-23.09M-1.67M-47.17M-10.66M
Net Cash FlowNCF
-1.38M-0.85M1.62M44.73M-13.88M20.79M32.11M28.71M-62.50M-28.18M235.87M-17.16M-58.75M-42.85M-15.70M6.95M-29.00M-8.61M144.45M3.96M
Interest Paid
0.05M1.58M0.10M1.58M0.17M1.65M0.23M1.69M0.25M1.65M0.19M1.45M0.00M1.44M0.00M0.01M0.01M0.00M
Income Taxes PaidTaxes Paid
-0.31M0.97M0.49M0.15M-0.39M0.06M0.31M0.21M0.12M0.17M0.24M0.11M0.06M0.20M-0.20M0.22M-0.07M-0.02M-0.01M

Standard Biotools Cash Flow Statement API

Pull Standard Biotools's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=LAB&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY